Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank P Smit

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Molecular Oncology|April 2, 2021
Androgen receptor signalling confers clonogenic and migratory advantages in urothelial cell carcinoma of the bladderMaria V Luna-Velez, Jelmer J Dijkstra, Marina A Heuschkel, et al.
The Journal of Urology|September 23, 2014
Dutasteride and enzalutamide synergistically suppress prostate tumor cell proliferationAgus Rizal A H Hamid, Gerald W Verhaegh, Frank P Smit, et al.
European Urology|December 4, 2012
Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancerGisele H J M Leyten, Daphne Hessels, Sander A Jannink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2015
Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate CancerGisele H J M Leyten, Daphne Hessels, Frank P Smit, et al.
European Urology|April 25, 2016
Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk ScoreLeander Van Neste, Rianne J Hendriks, Siebren Dijkstra, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Molecular Oncology|April 2, 2021
Androgen receptor signalling confers clonogenic and migratory advantages in urothelial cell carcinoma of the bladderMaria V Luna-Velez, Jelmer J Dijkstra, Marina A Heuschkel, et al.
The Journal of Urology|September 23, 2014
Dutasteride and enzalutamide synergistically suppress prostate tumor cell proliferationAgus Rizal A H Hamid, Gerald W Verhaegh, Frank P Smit, et al.
European Urology|December 4, 2012
Prospective multicentre evaluation of PCA3 and TMPRSS2-ERG gene fusions as diagnostic and prognostic urinary biomarkers for prostate cancerGisele H J M Leyten, Daphne Hessels, Sander A Jannink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2015
Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate CancerGisele H J M Leyten, Daphne Hessels, Frank P Smit, et al.
European Urology|April 25, 2016
Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk ScoreLeander Van Neste, Rianne J Hendriks, Siebren Dijkstra, et al.
Pageof 2